Orgenesis Profit Margin

Orgenesis posts a profit margin of 191.53% as of September 2024. That compares with 10.78% in the prior-year period — up 1676.0% year over year. That is above the Healthcare sector average of 21.34%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Orgenesis's profit margin was 10.78%. The latest reading is 191.53% — a 1676.0% year-over-year increase (period ending September 2024). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 21.34% is typical. Orgenesis's 191.53% is higher that level. That is roughly 797.7% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Orgenesis's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 191.53% as of September 2024; use YoY and peer views to separate noise from signal.

Context for ORGS's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 21.34%), and (3) consistency with growth and profitability. This page covers the first two; Orgenesis's other metric pages and overview cover the third.